Sign In
NewsRadar

Probiodrug

Probiodrug is a drug discovery company with a focus on distinct proteins as drug targets. The company aims to identify new orally active compounds for selectively modifying enzymatic activity in order to derive therapeutic effects in neuronal and autoimmune disorders. It works on QC–inhibition, a new approach to treat Alzheimer’s disease and other neurodegenerative disorders. Before QC, the company focused on DP 4 - inhibition for treatment of type 2 diabetes.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Weinbergweg 22
Halle/ Saale 06120
Germany
+49 345 55599-00
+49 345 55599-01
http://www.probiodrug.de
Konrad Glund
+49 345 55599-00

Company Facts
Founded:Dec 1997
Founders:Hans-Ulrich Demuth, Konrad Glund
CEO:Konrad Glund
CTO or technical lead:Mikael Thomsen
CFO or finance director:Hendrik Liebers
Head of Sales:
Head of Marketing:

Stage:Public
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,126
Tech investments
From our Online Data Service
16,881
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices
Sep 12€9.0MSoftware development

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.